Background The strategy of using fecal microbiota transplantation (FMT) for refractory
ulcerative colitis (UC) remains unclear if single FMT failed to induce remission. This study …

Background Corticosteroids remain the mainstay of first‐line therapy in active inflammatory
bowel disease. Aims To determine the clinical outcome after the first corticosteroid‐therapy …

Inflammatory bowel disease (IBD) encompasses two major entities: ulcerative colitis (UC)
and Crohn's disease (CD). 1 Both are chronic, progressive, disabling conditions that require …

Ulcerative colitis (UC) is a chronic relapsing and remitting gastrointestinal disorder of
uncertain aetiology. The last two decades have seen an expansion in the therapeutic …

The normal stress response in humans is governed by the hypothalamic-pituitary-adrenal
(HPA) axis through heightened mechanisms during stress, raising blood levels of the …

BACKGROUND The response to therapy in Crohn's disease (CD) depends on the
inflammatory or fibrostenotic nature of the underlying pathological process. Standard …

The objective of this study was to systematically review the literature to verify the efficacy and
safety of curcumin as a complementary therapy for the maintenance or induction of …

Background Many studies have examined the effects of exclusive enteral nutrition (EEN) in
children with Crohn's disease (CD), but corticosteroids are considered a superior therapy …

Curcumin belongs to the family of natural compounds collectively called curcuminoids and it
possesses remarkable beneficial anti-oxidant, anti-inflammatory, anti-cancer, and …

Background Cytomegalovirus (CMV) infection has been reported in ulcerative colitis (UC),
especially in severe, steroid-refractory disease. However, its role in steroid-refractoriness …